UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) |
Common Stock
Class A common stock
|
Common Stock
Class B common stock
|
Additional paid-in capital |
Subscription Receivable |
Retained Earnings (Accumulated Deficit) |
Class A common stock |
Class B common stock |
Total |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance at Dec. 31, 2023 | $ 60 | [1] | $ 52 | [1] | $ 6,996,275 | $ (600,000) | $ 508,241 | $ 6,904,628 | |||||||||
Beginning balance (in shares) at Dec. 31, 2023 | [1] | 604,125 | 515,625 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
Termination of equity-classified warrant | (78,125) | (78,125) | |||||||||||||||
Issuance of common stock for acquisition | $ 8 | [1] | 899,992 | 900,000 | |||||||||||||
Issuance of common stock for acquisition (in shares) | [1] | 79,521 | |||||||||||||||
Net loss from continuing operations for the period | (466,348) | (466,348) | |||||||||||||||
Net loss from discontinued operations for the period | (142,582) | (142,582) | |||||||||||||||
Ending balance at Mar. 31, 2024 | $ 68 | [1] | $ 52 | [1] | 7,818,142 | (600,000) | (100,689) | 7,117,573 | |||||||||
Ending balance (in shares) at Mar. 31, 2024 | [1] | 683,646 | 515,625 | ||||||||||||||
Beginning balance at Dec. 31, 2023 | $ 60 | [1] | $ 52 | [1] | 6,996,275 | (600,000) | 508,241 | 6,904,628 | |||||||||
Beginning balance (in shares) at Dec. 31, 2023 | [1] | 604,125 | 515,625 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
Net loss from continuing operations for the period | [2] | (1,016,370) | |||||||||||||||
Net loss from discontinued operations for the period | [2] | (205,440) | |||||||||||||||
Ending balance at Jun. 30, 2024 | $ 151 | [1] | $ 52 | [1] | 15,127,179 | (600,000) | (713,569) | 13,813,813 | |||||||||
Ending balance (in shares) at Jun. 30, 2024 | [1] | 1,509,271 | 515,625 | ||||||||||||||
Beginning balance at Mar. 31, 2024 | $ 68 | [1] | $ 52 | [1] | 7,818,142 | (600,000) | (100,689) | 7,117,573 | |||||||||
Beginning balance (in shares) at Mar. 31, 2024 | [1] | 683,646 | 515,625 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
Issuance of follow-on public offering | $ 83 | [1] | 7,309,037 | 7,309,120 | |||||||||||||
Issuance of follow-on public offering (in shares) | [1] | 825,625 | |||||||||||||||
Net loss from continuing operations for the period | (550,022) | (550,022) | [2] | ||||||||||||||
Net loss from discontinued operations for the period | (62,858) | (62,858) | [2] | ||||||||||||||
Ending balance at Jun. 30, 2024 | $ 151 | [1] | $ 52 | [1] | 15,127,179 | $ (600,000) | (713,569) | 13,813,813 | |||||||||
Ending balance (in shares) at Jun. 30, 2024 | [1] | 1,509,271 | 515,625 | ||||||||||||||
Beginning balance at Dec. 31, 2024 | $ 267 | [1] | $ 55 | [1] | 17,297,961 | (4,680,611) | $ 12,617,672 | [3] | |||||||||
Beginning balance (in shares) at Dec. 31, 2024 | 2,672,011 | [1] | 546,875 | [1] | 2,672,011 | 546,875 | 3,218,886 | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
Share-based compensation expenses | 16,185 | $ 16,185 | |||||||||||||||
Net loss from continuing operations for the period | (753,909) | (753,909) | |||||||||||||||
Ending balance at Mar. 31, 2025 | $ 267 | [1] | $ 55 | [1] | 17,314,146 | (5,434,520) | 11,879,948 | ||||||||||
Ending balance (in shares) at Mar. 31, 2025 | [1] | 2,672,011 | 546,875 | ||||||||||||||
Beginning balance at Dec. 31, 2024 | $ 267 | [1] | $ 55 | [1] | 17,297,961 | (4,680,611) | $ 12,617,672 | [3] | |||||||||
Beginning balance (in shares) at Dec. 31, 2024 | 2,672,011 | [1] | 546,875 | [1] | 2,672,011 | 546,875 | 3,218,886 | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
Net loss from continuing operations for the period | $ (1,266,437) | ||||||||||||||||
Ending balance at Jun. 30, 2025 | $ 267 | [1] | $ 55 | [1] | 17,324,590 | (5,947,048) | $ 11,377,864 | ||||||||||
Ending balance (in shares) at Jun. 30, 2025 | 2,672,011 | [1] | 546,875 | [1] | 2,672,011 | 546,875 | 3,218,886 | ||||||||||
Beginning balance at Mar. 31, 2025 | $ 267 | [1] | $ 55 | [1] | 17,314,146 | (5,434,520) | $ 11,879,948 | ||||||||||
Beginning balance (in shares) at Mar. 31, 2025 | [1] | 2,672,011 | 546,875 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||
Share-based compensation expenses | 10,444 | 10,444 | |||||||||||||||
Net loss from continuing operations for the period | (512,528) | (512,528) | |||||||||||||||
Ending balance at Jun. 30, 2025 | $ 267 | [1] | $ 55 | [1] | $ 17,324,590 | $ (5,947,048) | $ 11,377,864 | ||||||||||
Ending balance (in shares) at Jun. 30, 2025 | 2,672,011 | [1] | 546,875 | [1] | 2,672,011 | 546,875 | 3,218,886 | ||||||||||
|